Jeffrey Gudin
2022
In 2022, Jeffrey Gudin earned a total compensation of $285K as Executive VP, Chief Medical Officer at Virpax Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Option Awards | $81,000 |
|---|---|
| Salary | $157,000 |
| Stock Awards | $47,000 |
| Total | $285,000 |
Gudin received $157K in salary, accounting for 55% of the total pay in 2022.
Gudin also received $81K in option awards and $47K in stock awards.
Rankings
In 2022, Jeffrey Gudin's compensation ranked 5,144th out of 5,756 executives tracked by ExecPay. In other words, Gudin earned more than 10.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,144 out of 5,756 | 11th |
Division Manufacturing | 2,824 out of 3,133 | 10th |
Major group Chemicals And Allied Products | 1,312 out of 1,419 | 8th |
Industry group Drugs | 1,233 out of 1,320 | 7th |
Industry Pharmaceutical Preparations | 900 out of 966 | 7th |
Source: SEC filing on December 7, 2023.
Gudin's colleagues
We found two more compensation records of executives who worked with Jeffrey Gudin at Virpax Pharmaceuticals in 2022.